‘Sharp focus’ on well-positioned assets to drive Medicxi’s €500M Fund V

Medicxi is largely staying the course with its new fifth fund, planning to invest its capital in attractive assets rather than technology development projects that carry greater risk.

The new €500 million ($581.5 million) Medicxi V — the firm’s sixth fund since breaking away from Index Ventures in 2016 — will go into 20-25 companies, many of them newly created, Medicxi’s Giovanni Mariggi told BioCentury...